CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-14 | MASSARO GEORGE Director | Sale | −70 | $220.78 | $15K | 9,441 |
| 2020-08-20 | Girshick Birgit Corporate Executive VP | Sale | −933 | $213.51 | $199K | 22,852 |
| 2020-08-18 | CHUBB STEPHEN D Director | Gift | −110 | 38,657 | ||
| 2020-08-18 | CHUBB STEPHEN D Director | Sale | −700 | $217.25 | $152K | 37,957 |
| 2020-08-18 | CHUBB STEPHEN D Director | Sale | −300 | $218.58 | $66K | 37,657 |
| 2020-08-17 | CHUBB STEPHEN D Director | Gift | −460 | 38,767 | ||
| 2020-08-07 | MASSARO GEORGE Director | Gift | −500 | 11,384 | ||
| 2020-08-07 | Kochevar Deborah Turner Director | Sale | −2,319 | $216.24 | $501K | 6,728 |
| 2020-08-07 | FOSTER JAMES C Chairman, President and CEO | Sale | −4,713 | $216.34 | $1.0M | 230,064 |
| 2020-08-07 | FOSTER JAMES C Chairman, President and CEO | Sale | −19,287 | $217.77 | $4.2M | 210,777 |
| 2020-08-07 | Smith David Ross Corporate Executive VP & CFO | Option exercise | +3,304 | $144.67 | $478K | 24,071 |
| 2020-08-07 | Smith David Ross Corporate Executive VP & CFO | Sale | −2,297 | $216.42 | $497K | 21,774 |
| 2020-08-07 | Smith David Ross Corporate Executive VP & CFO | Sale | −1,007 | $216.82 | $218K | 20,767 |
| 2020-08-07 | Smith David Ross Corporate Executive VP & CFO | Option exercise · Stock Options (Right to Buy) | −3,304 | 9,914 | ||
| 2020-08-07 | Knell Michael Gunnar CSVP&Chief Accounting Officer | Option exercise | +997 | $90.43 | $90K | 3,411 |
| 2020-08-07 | Knell Michael Gunnar CSVP&Chief Accounting Officer | Option exercise | +1,709 | $109.34 | $187K | 5,120 |
| 2020-08-07 | Knell Michael Gunnar CSVP&Chief Accounting Officer | Option exercise | +735 | $144.67 | $106K | 5,855 |
| 2020-08-07 | Knell Michael Gunnar CSVP&Chief Accounting Officer | Sale | −2,793 | $216.52 | $605K | 3,062 |
| 2020-08-07 | Knell Michael Gunnar CSVP&Chief Accounting Officer | Sale | −663 | $216.93 | $144K | 2,399 |
| 2020-08-07 | Knell Michael Gunnar CSVP&Chief Accounting Officer | Option exercise · Stock Options (Right to Buy) | −997 | 333 |
Page 51 of 60 · 1,185 trades